The Board of Directors of Chengdu Easton Biopharmaceuticals Co., Ltd. has authorized a buyback plan on August 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
56.1 CNY | -1.02% | +1.81% | -12.04% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.04% | 922M | |
+48.79% | 781B | |
-7.23% | 350B | |
+19.43% | 330B | |
+7.18% | 293B | |
+17.26% | 248B | |
-0.04% | 221B | |
+11.42% | 217B | |
+4.53% | 162B | |
-3.92% | 157B |
- Stock Market
- Equities
- 688513 Stock
- News Chengdu Easton Biopharmaceuticals Co., Ltd.
- Chengdu Easton Biopharmaceuticals Co., Ltd. authorizes a Buyback Plan.